TrialJournal of the National Cancer Institute2021

Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial.

Céline Callens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.